148 related articles for article (PubMed ID: 34260532)
21. A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE).
Ito H; Ouchi Y; Ohashi Y; Saito Y; Ishikawa T; Nakamura H; Orimo H
J Atheroscler Thromb; 2001; 8(2):33-44. PubMed ID: 11770708
[TBL] [Abstract][Full Text] [Related]
22. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
Sawayama Y; Shimizu C; Maeda N; Tatsukawa M; Kinukawa N; Koyanagi S; Kashiwagi S; Hayashi J
J Am Coll Cardiol; 2002 Feb; 39(4):610-6. PubMed ID: 11849859
[TBL] [Abstract][Full Text] [Related]
23. [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].
Wu CJ; Wang L; Li X; Wang CX; Ma JP; Xia XS
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1003-8. PubMed ID: 23363713
[TBL] [Abstract][Full Text] [Related]
24. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.
Waeber B; Greminger P; Riesen W; Darioli R; Simeon-Dubach D; Wunderlin R
Blood Press; 1995 Nov; 4(6):358-62. PubMed ID: 8746603
[TBL] [Abstract][Full Text] [Related]
26. Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment.
Kawano H; Yano K
Circ J; 2006 Sep; 70(9):1116-21. PubMed ID: 16936421
[TBL] [Abstract][Full Text] [Related]
27. Effects of folic acid combined with vitamin B12 on DVT in patients with homocysteine cerebral infarction.
Shu XJ; Li ZF; Chang YW; Liu SY; Wang WH
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2538-2544. PubMed ID: 28617530
[TBL] [Abstract][Full Text] [Related]
28. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study.
Mercuri M; Bond MG; Sirtori CR; Veglia F; Crepaldi G; Feruglio FS; Descovich G; Ricci G; Rubba P; Mancini M; Gallus G; Bianchi G; D'Alò G; Ventura A
Am J Med; 1996 Dec; 101(6):627-34. PubMed ID: 9003110
[TBL] [Abstract][Full Text] [Related]
29. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
[TBL] [Abstract][Full Text] [Related]
30. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yokoi H; Yoshida M;
Circ J; 2012; 76(1):221-9. PubMed ID: 22094911
[TBL] [Abstract][Full Text] [Related]
31. [Effect of pravastatine plus ezetimibe on carotid intima media thickness in patients with lupus erythematosus].
Vera-Lastra OL; Olvera-Acevedo A; Hernández C; Medina G; Carrillo-González AL; Ángeles-Garay U; Peralta-Amaro AL; Jara L
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 1():S74-9. PubMed ID: 26020669
[TBL] [Abstract][Full Text] [Related]
32. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
[TBL] [Abstract][Full Text] [Related]
33. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
Fliser D; Buchholz K; Haller H;
Circulation; 2004 Aug; 110(9):1103-7. PubMed ID: 15313950
[TBL] [Abstract][Full Text] [Related]
34. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD
Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results.
Zoungas S; Branley P; Kerr PG; Ristevski S; Muske C; Demos L; Atkins RC; Becker G; Fraenkel M; Hutchison BG; Walker R; McNeil JJ; McGrath BP
Nephrology (Carlton); 2004 Jun; 9(3):130-41. PubMed ID: 15189174
[TBL] [Abstract][Full Text] [Related]
36. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
[TBL] [Abstract][Full Text] [Related]
37. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
[TBL] [Abstract][Full Text] [Related]
38. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
[TBL] [Abstract][Full Text] [Related]
39. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.
Borghi C; Prandin MG; Costa FV; Bacchelli S; Degli Esposti D; Ambrosioni E
J Cardiovasc Pharmacol; 2000 Apr; 35(4):549-55. PubMed ID: 10774784
[TBL] [Abstract][Full Text] [Related]
40. Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infarction.
Kametsu Y; Kitagawa Y; Sekiyama S; Takagi S
Tokai J Exp Clin Med; 2005 Sep; 30(3):171-6. PubMed ID: 16285608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
